We are studying if oral vancomycin can help prevent infections in patients receiving allogeneic stem cell transplants. This research aims to see if it reduces the risk of Clostridium difficile infections during their hospital stay.
Health conditions and diseases that the clinical trial is designed to study and treat.
Clostridium difficile infection (CDI) is a bacterial infection that can cause severe diarrhea and inflammation of the colon, often occurring after antibiotic use. It can lead to serious complications, especially in hospitalized patients.
Patients hospitalized for allogeneic hematopoietic stem cell transplantation are individuals receiving stem cells from a donor to treat various blood disorders. This procedure can weaken the immune system, making patients more susceptible to infections.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.